PCN168 MEDICAL RESOURCE UTILIZATION (MRU) OF APALUTAMIDE (APA) PLUS ANDROGEN DEPRIVATION THERAPY (ADT) IN NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC) AND METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER (MCSPC): RESULTS FROM SPARTAN AND TITAN
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI